brl 42810 has been researched along with Hepatitis, Infectious in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lamivudine 3 mg/kg was administered on a compassionate-use basis for 14-36 months." | 1.31 | Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children. ( Bar-Nathan, N; Ben-Ari, Z; Dinari, G; Mor, E; Shapira, R; Sokal, EM; Tur-Kaspa, R, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shapira, R | 1 |
| Mor, E | 1 |
| Bar-Nathan, N | 1 |
| Sokal, EM | 1 |
| Tur-Kaspa, R | 1 |
| Dinari, G | 1 |
| Ben-Ari, Z | 1 |
1 other study available for brl 42810 and Hepatitis, Infectious
| Article | Year |
|---|---|
Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
Topics: 2-Aminopurine; Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Cystic F | 2001 |